Internal restructuring
Location of affected unit(s)
Spain, Brazil
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

165 jobs
Number of planned job losses
Job loss
Announcement Date
12 November 2021
Employment effect (start)
12 November 2021
Foreseen end date


Spanish life science company Grifols has announced that it will cut at least 165 jobs worldwide. The company has decided to liquidate its blood bag division in Spain and Brazil. In Spain, the company is to cut 165 jobs at its site in Murcia. The closure is to affect the blood bag business, which is very unprofitable for the company; the whey business is to remain operational. In Brazil, Grifols is in the process of liquidating the factory, but no information has been provided yet on the number of affected jobs. The programme will be negotiated with workers’ representatives. Representatives hope the company uses natural early retirement measures and internal relocations within the structure as much as possible.

Grifols has been operating since 1909. The company has four divisions: bioscience, diagnostic, hospital, and bio supplies. Currently, it has over 30 subsidiaries, globally employs about 24,000 people and sells its products in more than 100 countries.



Eurofound (2021), Grifols, Internal restructuring in World, factsheet number 106024, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/106024.